Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after transcatheter aortic valve replacement.

AIMS This study aimed to assess the impact of valvular/subvalvular calcium burden on procedural and long-term outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS). METHODS AND RESULTS In this prospective observational cohort study, we included patients with AS undergoing TAVR between March 2010 and December 2019. Calcium burden at baseline was quantified using multidetector computed tomography and the patients were classified into tertile groups according to the amount of calcium. Procedural outcomes [paravalvular leakage (PVL) or permanent pacemaker insertion (PPI)] and 12-month clinical outcomes (composite of death, stroke, or rehospitalization, and all-cause mortality) were assessed. A total of 676 patients (age, 79.8 ± 5.4 years) were analysed. The 30-day rates of moderate or severe PVL (P-for-trend = 0.03) and PPI (P-for-trend = 0.002) proportionally increased with the tertile levels of calcium volume. The 12-month rate of primary composite outcomes was 34.2% in low-tertile, 23.9% in middle-tertile, and 25.8% in high-tertile groups (log-rank P = 0.02). After multivariable adjustment, the risk for primary composite outcomes at 12 months was not significantly different between the tertile groups of calcium volume [reference = low-tertile; middle-tertile, hazard ratio (HR) 0.81; 95% confidence interval (CI) 0.54-1.22; P = 0.31; high-tertile, HR 0.93; 95% CI 0.56-1.57; P = 0.80]. A similar pattern was observed for all-cause mortality. CONCLUSION The rates of PVL and PPI proportionally increased according to the levels of valvular/subvalvular calcium volume, while the adjusted risks for composite outcomes and mortality at 12 months were not significantly different.

[1]  D. Berman,et al.  Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium. , 2020, European heart journal cardiovascular Imaging.

[2]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[3]  D. Dey,et al.  Non-calcific aortic tissue quantified from computed tomography angiography improves diagnosis and prognostication of patients referred for transcatheter aortic valve implantation. , 2020, European heart journal cardiovascular Imaging.

[4]  A. Huber,et al.  Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement. , 2020, JACC. Cardiovascular interventions.

[5]  Jeroen J. Bax,et al.  How valvular calcification can affect the outcomes of transcatheter aortic valve implantation , 2020, Expert review of medical devices.

[6]  T. Bertsch,et al.  Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement. , 2019, Journal of cardiovascular computed tomography.

[7]  Seung‐Jung Park,et al.  Computed Tomography Features of Cuspal Thrombosis and Subvalvular Tissue Ingrowth after Transcatheter Aortic Valve Implantation. , 2019, The American journal of cardiology.

[8]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[9]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[10]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[11]  P. Pibarot,et al.  Severe aortic stenosis with low aortic valve calcification: characteristics and outcome following transcatheter aortic valve implantation , 2017, European heart journal cardiovascular Imaging.

[12]  Jeroen J. Bax,et al.  Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. , 2016, Journal of the American College of Cardiology.

[13]  L. Conradi,et al.  Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices. , 2016, European heart journal cardiovascular Imaging.

[14]  M. Enriquez-Sarano,et al.  Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. , 2014, Journal of the American College of Cardiology.

[15]  D. Berman,et al.  A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. , 2014, European heart journal cardiovascular Imaging.

[16]  Catherine M. Otto,et al.  Aortic-valve stenosis--from patients at risk to severe valve obstruction. , 2014, The New England journal of medicine.

[17]  G. Feuchtner,et al.  Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement , 2013, Circulation.

[18]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[19]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[20]  C. Becker,et al.  Reproducibility of coronary calcium quantification in repeat examinations with retrospectively ECG-gated multisection spiral CT , 2002, European Radiology.